Get the Stockscreener App
18.08
4.09%
0.71
Scilex Holding Company stock is traded at $18.08, with a volume of 540.39K.
It is up +4.09% in the last 24 hours and up +168.65% over the past month.
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
See More
Previous Close:
$17.37
Open:
$17.62
24h Volume:
540.39K
Relative Volume:
3.06
Market Cap:
$125.69M
Revenue:
$46.74M
Net Income/Loss:
$-114.33M
P/E Ratio:
-14.02
EPS:
-1.29
Net Cash Flow:
$-21.04M
1W Performance:
+15.01%
1M Performance:
+168.65%
6M Performance:
+45.92%
1Y Performance:
-58.34%
1-Day Range:
$17.40
$20.40
1-Week Range:
$15.37
$22.01
52-Week Range:
$3.60
$46.20
Scilex Holding Company Stock (SCLX) Company Profile
Name
Scilex Holding Company
Sector
Industry
Phone
(650) 516-4310
Address
960 SAN ANTONIO ROAD, PALO ALTO
Compare SCLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCLX
Scilex Holding Company
|
18.08 | 98.10M | 46.74M | -114.33M | -21.04M | -1.29 |
|
LLY
Lilly Eli Co
|
701.23 | 613.56B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
176.64 | 420.78B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
206.69 | 361.58B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
124.21 | 236.35B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
84.21 | 206.72B | 63.43B | 16.42B | 14.72B | 6.49 |
Scilex Holding Company Stock (SCLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-25 | Initiated | D. Boral Capital | Buy |
| Oct-16-24 | Initiated | Alliance Global Partners | Buy |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-16-23 | Initiated | B. Riley Securities | Buy |
| Oct-13-23 | Initiated | B. Riley Securities | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
View All
Scilex Holding Company Stock (SCLX) Latest News
Scilex gains on spinoff plans for pharma subsidiary - MSN
Scilex Holding Soars 20.81% on SEC Approval, Funding, Partnership - AInvest
Scilex Holding Company Equity Warrant Stock Lags Behind Sector BenchmarksJuly 2025 Chart Watch & Free Low Drawdown Momentum Trade Ideas - beatles.ru
Scilex Holding Company shares fall 1.14% after-hours as SEC declares effectiveness of S-4 filing for Denali-Semnur merger. - AInvest
Scilex Holding Company ($SCLX) Stock: Surges Over 17% as SEC Clears Path for Denali-Semnur Merger Vote in September - CoinCentral
Scilex Holding shares surge 13.84% intraday after SEC approves Denali Capital Acquisition Corp. and Semnur Pharmaceuticals merger. - AInvest
Scilex Holding Company shares rise 6.34% premarket after announcing $100 million in funding from Tumim Stone Capital. - AInvest
Scilex Holding Company Announces S-4 Effectiveness, Denali-Semnur Merger Proposal, and Oramed Pharmaceuticals Enters Option Agreement with Scilex - AInvest
Scilex announces S-4 effectiveness for Denali-Semnur merger proposal - MarketScreener
Scilex Holding Company (Nasdaq: SCLX) Announces - GlobeNewswire
Denali's registration statement declared effective, extraordinary meeting scheduled. - AInvest
Scilex Announces Effectiveness of Registration Statement for Proposed Business Combination with Semnur Pharmaceuticals - AInvest
Biotech firm Scilex Advances SPAC Deal as SEC Approves Merger Registration for Pain Treatment Subsidiary - Stock Titan
Analysts Apply Wyckoff Model to Scilex Holding Company StockWeekly Trade Review & High Return Trade Opportunity Guides - beatles.ru
Scilex Holding Co expected to post a loss of 91 cents a shareEarnings Preview - TradingView
Scilex (SCLX) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Scilex Holding SCLX 2025Q2 Earnings Preview Upside Potential on Robust Revenue Growth - AInvest
Scilex Holding WRT SCLXW Q2 2025 Earnings Preview Upside Potential on Improved Cost Management - AInvest
Using R and stats models for Scilex Holding Company forecastingChart Based Entry Tool for ROI Traders - Newser
Quantitative breakdown of Scilex Holding Company recent moveYield Curve Outlook and Long-Term Implication Summary - Newser
How Scilex Holding Company Equity Warrant stock performs during market volatilityForecasting Stock Moves with AI Insights - Newser
Full technical analysis of Scilex Holding Company Equity Warrant stockFree Expert Verified Stock Trade Ideas - Newser
Is Scilex Holding Company Equity Warrant stock a growth or value playFree Capital Protection Trading Strategies - Newser
Scilex Holding Company Announces that Its Note Holders Intend to Participate in the Funding and Licensing of Gloperba® Ex-U.S. Commercialization Rights from Romeg Therapeutics, LLC - The Globe and Mail
Scilex Holding Company Announces that the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for ELYXYB® in Acute Pain Indication - The Globe and Mail
Scilex Holding Company Equity Warrant stock momentum explainedHigh Confidence Strategy with Trend Alignment - Newser
Should you wait for a breakout in Scilex Holding Company Equity WarrantShort Term Momentum Based Trading Strategy - Newser
Is Scilex Holding Company meeting your algorithmic filter criteriaPre-Market Stock Movement Summary and Review - Newser
Using Python tools to backtest Scilex Holding Company strategiesReal-Time Investment Picks with Accuracy - Newser
Competitive Positioning of Scilex Holding Company: Is It Leading or LaggingAlpha Stock Picks with Chart Confirmation - Newser
Scilex Holding Company stock trendline breakdownFree Fast Entry High Potential Stock Alerts - Newser
Can swing trading help recover from Scilex Holding Company Equity Warrant lossesFree Real Market Momentum Signal Generator - Newser
Live market analysis of Scilex Holding Company Equity WarrantFree Investment Plan With Growth Optimization - Newser
Scilex Holding Company Equity Warrant Company’s Quarterly Earnings Growth: What the Numbers SayFree Short Term Buy List With Stop Protection - Newser
Scilex files to sell 1.39M shares of common stock for holders - MSN
Backtesting results for Scilex Holding Company Equity Warrant trading strategiesExpert-Backed High Yield Stock Watchlist - Newser
What high frequency data says about Scilex Holding CompanySwing Entry Risk Mitigation with Chart Analysis - Newser
[S-1] Scilex Holding Company Warrant Files IPO Registration Statement | SCLXW SEC FilingForm S-1 - Stock Titan
Scilex Holding Company’s Beta Climbs After Market VolatilityCommunity Strategy With High Win Rate Backtested - metal.it
What are Scilex Holding Company company’s key revenue driversUnlock real-time trading signals for gains - Jammu Links News
Risk adjusted return profile for Scilex Holding Company Equity Warrant analyzedCapital Safe Picks with Consistent Gains - Newser
Is it the right time to buy Scilex Holding Company stockAchieve consistent returns with proven methods - Jammu Links News
What is the risk reward ratio of investing in Scilex Holding Company stockUnlock powerful market analysis and alerts - Jammu Links News
What catalysts could drive Scilex Holding Company Equity Warrant stock higher in 2025Outstanding stock performance - Jammu Links News
How strong is Scilex Holding Company company’s balance sheetBuild wealth steadily with proven stock picks - Jammu Links News
How does Scilex Holding Company Equity Warrant generate profit in a changing economyAchieve consistent profits with expert strategies - Jammu Links News
Is it the right time to buy Scilex Holding Company Equity Warrant stockRapid growth opportunities - Jammu Links News
Why is Scilex Holding Company Equity Warrant stock attracting strong analyst attentionExceptional ROI - Jammu Links News
Is Scilex Holding Company Equity Warrant a growth stock or a value stockTriple-digit wealth increases - Jammu Links News
Is Scilex Holding Company a good long term investmentHigh-velocity capital appreciation - Jammu Links News
Scilex Holding Company Stock Analysis and ForecastUnlock steady growth with low-risk stocks - Jammu Links News
Scilex Holding Company Stock (SCLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.49%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):